Switch to:
More From Other Websites
3:47 am Roche Hldg's Rituxan receives Breakthrough Therapy Designation from FDA Mar 26 2017
Roche's Rituxan Gets 'Breakthrough Therapy' Designation by FDA Mar 24 2017
Big Decision Week for Roche, GSK, Sanofi, Mylan Mar 24 2017
Roche’s Rituxan Secures FDA Breakthrough Designation (RHHBY) Mar 24 2017
Pfizer, Merck KGaA Get FDA Nod for Skin Cancer Drug (PFE) Mar 24 2017
FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris Mar 24 2017
Dow's Merck Swipes Immuno-Oncology Share From Heavyweight Rivals Mar 22 2017
Should Value Investors Pick Roche Holding (RHHBY)? Mar 22 2017
Roche Restructuring Shows Trouble in US Diabetes Biz Mar 17 2017
Why Is Prothena (PRTA) Up 4.5% Since the Last Earnings Report? Mar 17 2017
New MagNA Pure 24 System by Roche offers labs improved flexibility and automation Mar 17 2017
Yestar Healthcare Holdings Company Limited -- Moody's: Yestar's 2016 results are in line with... Mar 16 2017
Glaxo Seeks Label Expansion for Fluarix Vaccine Mar 16 2017
Celldex (CLDX) Shares Up as Q4 Loss Narrows; Sales Beat Mar 15 2017
Roche launches the cobas® EGFR Mutation Test v2 for use with either plasma or tumor tissue samples Mar 14 2017
Roche launches the cobas® EGFR Mutation Test v2 for use with either plasma or tumor tissue samples Mar 14 2017
It’s time to vaccinate your investments against a deadly bird flu Mar 14 2017
Mylan, Roche Ink Global Deal for Herceptin Biosimilar Mar 13 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK